AF
IMGN

Amalgamated Financial’s Immunogen Inc IMGN Stock Holding History

Amalgamated Financial’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$135K Buy
+28,412
New +$157K ﹤0.01% 2044

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amalgamated Financial's IMGN Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Immunogen Inc (IMGN) in Q1 2022: 28,412 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #2044 among its holdings.

217 funds tracked by Wall St. Rank hold IMGN as of Q1 2022.

  • Amalgamated Financial held 28,412 shares of Immunogen Inc worth $135K as of Q1 2022.
  • Immunogen Inc was a new Amalgamated Financial position in Q1 2022.
  • Immunogen Inc made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2044 holding.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.